Epilepsy, Generalized

12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Brain Diseases, Epilepsy, Nervous System Diseases

Narrower: Epilepsies, Myoclonic 7, Epilepsy, Absence 2, Myoclonic Epilepsy, Juvenile 1, Spasms, Infantile 2

Treatments and conditions

Epilepsy, Generalized
Treatment and conditionWhere it standsTrials
30mg PRAX-628 for epilepsy, generalizedPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bexicaserin for epilepsies, myoclonicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivaracetam for epilepsy, absencePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cannabidiol for epilepsies, myoclonicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Cannabidiol for epilepsy, absenceTrials ended early, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol for spasms, infantilePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
ETX101 for epilepsies, myoclonicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
ION337 for epilepsies, myoclonicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
JZP926 capsule for myoclonic epilepsy, juvenilePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Relutrigine for spasms, infantilePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
STK-001 - Single Ascending Doses for epilepsies, myoclonicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zorevunersen for epilepsies, myoclonicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.